摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,5-Bis[di(2-pyridylmethyl)aminomethyl]imidazole | 256464-12-7

中文名称
——
中文别名
——
英文名称
4,5-Bis[di(2-pyridylmethyl)aminomethyl]imidazole
英文别名
4,5-bis(di(2-pyridylmethyl)aminomethyl)imidazole;N-[[4-[[bis(pyridin-2-ylmethyl)amino]methyl]-1H-imidazol-5-yl]methyl]-1-pyridin-2-yl-N-(pyridin-2-ylmethyl)methanamine
4,5-Bis[di(2-pyridylmethyl)aminomethyl]imidazole化学式
CAS
256464-12-7
化学式
C29H30N8
mdl
——
分子量
490.611
InChiKey
ORAJWXXVFNETII-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    37
  • 可旋转键数:
    12
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    86.7
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    copper(II) perchlorate hexahydrate 、 4,5-Bis[di(2-pyridylmethyl)aminomethyl]imidazole 在 NEt3 作用下, 以 甲醇 为溶剂, 生成
    参考文献:
    名称:
    A novel imidazolate-bridged copper–zinc heterodinuclear complex as a Cu, Zn–SOD active site model
    摘要:
    合成了一种含有两个金属结合基团的咪唑衍生物咪唑桥联Cu(II)-Zn(II)异双核配合物,并阐明了其结构和性能。
    DOI:
    10.1039/a906226b
  • 作为产物:
    描述:
    二甲基吡啶胺imidazole-4,5-dicarbodialdehyde 在 sodium cyanoborohydride 、 溶剂黄146 作用下, 以 甲醇 为溶剂, 反应 72.0h, 以80%的产率得到4,5-Bis[di(2-pyridylmethyl)aminomethyl]imidazole
    参考文献:
    名称:
    A novel imidazolate-bridged copper–zinc heterodinuclear complex as a Cu, Zn–SOD active site model
    摘要:
    合成了一种含有两个金属结合基团的咪唑衍生物咪唑桥联Cu(II)-Zn(II)异双核配合物,并阐明了其结构和性能。
    DOI:
    10.1039/a906226b
点击查看最新优质反应信息

文献信息

  • Synthesis and Characterization of Imidazolate-Bridged Dinuclear Complexes as Active Site Models of Cu,Zn-SOD
    作者:Hideki Ohtsu、Yuichi Shimazaki、Akira Odani、Osamu Yamauchi、Wasuke Mori、Shinobu Itoh、Shunichi Fukuzumi
    DOI:10.1021/ja994050j
    日期:2000.6.1
    New dinucleating ligands having two metal-binding sites bridged by an imidazolate moiety, Hbdpi and HMe(4)bdpi (Hbdpi = 4,5-bis(di(2-pyridylmethyl)aminomethyl)imidazole, HMe(4)bdpi = 4,5-bis(di(6-methyl -2-pyridylmethyl)aminomethyl)imidazole), have been designed and synthesized as model ligands for copper-zinc superoxide dismutase (Cu,Zn-SOD). The corresponding mononucleating ligand, MeIm(Py)(2) (MeIm(Py)(2) = ((1-methyl-4-imidazolyl)methyl)bis(2-pyridylmethyl)amine), has also been synthesized for comparison. The imidazolate-bridged Cu(II)-Cu(II) homodinuclear complexes represented as [Cu-2(bdpi)(CH3CN)(2)](ClO4)(3). CH3-CN . 3H(2)O (1), [Cu-2(Me(4)bdi)(H2O)(2)](ClO4)(3). 4H(2)O (2), a Cu(II)-Zn(II) heterodinuclear complex of the type of [CuZn(bdpi)(CH3CN)(2)](ClO4)(3). 2CH(3)CN (3), and a Cu(II) mononuclear complex of [Cu(MeIm(Py)(2)(CH3CN)](ClO4)(2). CH3CN (4) have been synthesized, and the structures of complexes 1-4 were determined by X-ray crystallography. The Cu(II)-Zn(II) distance of 6.197(2) Angstrom in 3 agrees well with that of native Cu,Zn-SOD (6.2 Angstrom). All the metals in 1-4 have pentacoordinate geometries with the imidazolate or 1-methylimidazole nitrogen, two pyridine nitrogens, the tertiary amine nitrogen, and a solvent (CH3CN or H2O). The coordination site occupied by a solvent can be susceptible to ligand substitution, providing a binding site for substrate superoxide. Magnetic measurements of the Cu(II)-Cu(II) homodinuclear complexes 1 and 2 have shown an antiferromagnetic exchange interaction with a coupling constant of -2J = 73.4 and 145.9 cm(-1), respectively. The ESR spectra of 1 and 2 exhibited broad signals centered at g congruent to 2.13 due to the spin-spin interaction between two copper ions, while the ESR spectrum of the Cu(II)-Zn(II) heterodinuclear complex 3 showed a signal which is characteristic of mononuclear trigonal-bipyramidal Cu(II) complexes (g(parallel to) = 2.10, g(perpendicular to) = 2.24, /A(parallel to)/= 11.7 mT, and /A(perpendicular to)/= 12.4 mT). The cyclic voltammograms of homodinuclear complexes (1 and 2) in CH3CN gave two reversible waves which correspond to the Cu(I,I)/Cu(I,II) and Cu(I,II)/Cu(II,II) redox processes: E-1/2 = -0.31 and -0.03 V vs Ag/AgCl for 1 and E-1/2 = -0.29 and +0.12 V vs Ag/AgCl for 2, respectively. On the other hand, the Cu(II)-Zn(II) heterodinuclear complex 3 exhibited one Cu(I)/(II) reversible wave, E-1/2 = -0.03 V vs Ag/AgCl, which is shifted in a positive direction (0.21 and 0.19 V) as compared to those of the corresponding Cu(II) mononuclear complexes. All the examined complexes catalyzed the dismutation of superoxide at biological pH; the SOD activity increased in the order 2 < 1 < 3.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-